Case Details
- Citation: [2014] SGCA 29
- Title: Teo Chong Nghee Patrick and others v Han Cheng Fong and another appeal
- Court: Court of Appeal of the Republic of Singapore
- Date of Decision: 23 May 2014
- Case Numbers: Civil Appeal Nos 36 and 37 of 2013
- Coram: Sundaresh Menon CJ; Andrew Phang Boon Leong JA; V K Rajah JA
- Judgment Author: V K Rajah JA (delivering the grounds of decision of the court)
- Appellants (CA 36): Teo Chong Nghee Patrick; Lim Shih Hsi (Richard); Michael Heng Swee Hai (Michael); Cleantech Partners Pte Ltd (CTP)
- Appellants (CA 37): CTP and Cleantech Partners Hangzhou Pte Ltd (CTP-HZ)
- Respondents (CA 36): Han Cheng Fong (Dr Han); Liew Sok Kuan (Christine); Low Soo Chee (Robin)
- Respondents (CA 37): Dr Han; Christine; Robin; International Eco-City Pte Ltd (IEC)
- Parties’ Roles: Joint venture partners and founder directors of CTP; Dr Han and Christine removed from director positions in CTP-HZ
- Legal Areas: Companies – directors’ removal; Tort – conspiracy
- Statutes Referenced: Companies Act
- Related High Court Decisions: [2013] SGHC 51; [2013] SGHC 52
- Cases Cited: [2013] SGHC 51; [2013] SGHC 52; [2014] SGCA 29
- Representation (CA 36 & CA 37): Chan Kia Pheng, Tan Wei Ming and Neo Ming Wei Douglas (KhattarWong LLP) for the appellants; Lee Hwee Khiam Anthony and Pua Lee Siang (Bih Li & Lee) for the respondents
- Procedural History: Appeal from High Court decisions in Suit 908 of 2010 and Suit 266 of 2011 heard together before Tan Lee Meng J
- Judgment Length: 10 pages, 5,699 words
Summary
This Court of Appeal decision arose from a breakdown in a Singapore-led joint venture concerning a low carbon eco-park development in Hangzhou, China. The dispute centred on the removal of Dr Han Cheng Fong (“Dr Han”) and Christine from their director positions in the joint venture company, CTP-HZ. Dr Han sued for wrongful removal and conspiracy, while the opposing faction counter-sued for breach of fiduciary duties and conspiracy, alleging that Dr Han and others used unlawful means to force the eviction of CTP-HZ from the Hangzhou project.
The High Court had found in Dr Han’s favour in Suit 908 (wrongful removal), holding that a document signed on 1 March 2010 (“the 1 March document”) was a binding shareholders’ agreement conferring an enforceable right (or at least a legitimate expectation) that Dr Han would remain as chairman and director unless justifiably dismissed. In the counter-suit (Suit 266), the High Court dismissed the claims against Dr Han for conspiracy and breach of fiduciary duties.
On appeal, the Court of Appeal allowed CA 36 (relating to Suit 908) and dismissed CA 37 (relating to Suit 266). The Court disagreed with the High Court’s legal characterisation of the 1 March document as a legally enforceable agreement granting Dr Han enforceable rights to his positions. The Court also held that Dr Han failed to establish legally recoverable loss. As for CA 37, the Court saw no basis to overturn the High Court’s factual findings and therefore upheld the dismissal of the counter-claims.
What Were the Facts of This Case?
The parties were founder directors of Cleantech Partners Pte Ltd (“CTP”), which was used as the corporate vehicle for a Hangzhou Singapore Eco-Park Development Project. CTP-HZ, a wholly owned subsidiary of CTP, served as a special purpose vehicle (SPV) for the Hangzhou project. The SPV was intended to operate through a funding and collaboration arrangement with two Chinese partners: Hangzhou Vanwarm Holdings Group Ltd (“Vanwarm”) and the Hangzhou Qianjiang Economic Development Area Management Committee (“HQEDA”).
In September 2009, four individuals—Michael Heng Swee Hai (“Michael”), Teo Chong Nghee Patrick (“Patrick”), Lim Shih Hsi (“Richard”), and Robin—decided to undertake the Hangzhou project and invited Dr Han to participate because of his expertise in the property sector in China. Christine was brought in at Dr Han’s request to assist him. The parties wanted their involvement and roles recorded, and the 1 March document was signed on 1 March 2010 to reflect the agreed structure and governance arrangements.
The 1 March document was headed as a “DIRECTORS’ RESOLUTION IN WRITING PASSED PURSUANT TO THE COMPANY’S ARTICLES OF ASSOCIATION” and set out, among other things, the appointment of Dr Han as Deputy Chairman of CTP and Christine as a director, along with the allocation of ordinary shares among the directors. It also contained provisions relating to the directors’ review of equity value, the establishment of CTP-HZ as a 100% subsidiary SPV, and the composition of CTP-HZ’s board of directors. In particular, it stated that CTP-HZ Board of Directors would consist of all six directors of CTP, with Dr Han as Chairman and Christine as CEO.
After the 1 March document, CTP-HZ entered into a collaboration agreement with Vanwarm and a third party on 31 May 2010. The collaboration agreement included a guaranteed profit arrangement of RMB$130 million in return for paid-up capital. However, it was not registered with Chinese authorities and was therefore unenforceable under Chinese law. Over time, relationships deteriorated. By April 2010, cracks had appeared, and on 12 October 2010 Patrick called an extraordinary meeting of CTP-HZ to remove Dr Han and Christine as directors. Dr Han was not given notice of the meeting, and the resolutions were passed. Attempts at reconciliation failed, and on 2 February 2011 Vanwarm terminated the collaboration agreement, citing internal problems at CTP.
In parallel, the parties also disputed whether certain business opportunities were diverted away from CTP and CTP-HZ. The counter-claims alleged that Dr Han and others hijacked potential opportunities and conspired to file Suit 908 to force the eviction of CTP-HZ from the Hangzhou project. The High Court heard both suits together over 27 days and delivered separate decisions: Suit 908 in Dr Han’s favour, and Suit 266 against Dr Han’s opponents.
What Were the Key Legal Issues?
The first central issue in CA 36 was whether the 1 March document created a legally enforceable shareholders’ agreement (or other binding contractual or equitable arrangement) that conferred on Dr Han an enforceable right to remain as chairman and director of CTP-HZ, such that his removal would be wrongful. The High Court had held that the document was binding and that Dr Han had at least a legitimate expectation to remain in those positions unless justifiably dismissed. The Court of Appeal had to decide whether that legal characterisation was correct.
A second issue in CA 36 was damages and causation: even if Dr Han’s removal were wrongful, Dr Han had to show legally recoverable loss. The Court of Appeal considered whether the losses claimed were sufficiently established and whether the alleged guaranteed profit under the collaboration agreement could be treated as recoverable loss in the circumstances, given that the collaboration agreement was unenforceable under Chinese law.
For CA 37, the key issue was whether the High Court was correct to dismiss the counter-claims for conspiracy and breach of fiduciary duties. This required the Court of Appeal to consider whether there was any basis to overturn the High Court’s factual findings, particularly those relating to alleged conspiratorial conduct and the alleged diversion of business opportunities.
How Did the Court Analyse the Issues?
The Court of Appeal approached CA 36 by focusing on the legal effect of the 1 March document. While the High Court treated the document as a binding shareholders’ agreement, the Court of Appeal disagreed. The Court accepted that it would not interfere with the trial judge’s findings of fact, but emphasised that “much turned on the legal effect” of the document. This distinction is important: the appellate court’s task was not to re-litigate factual matters already found, but to determine whether the document, properly construed, created enforceable rights.
In analysing the document, the Court considered its form and content, including its heading as a directors’ written resolution passed pursuant to the company’s articles of association. The Court’s reasoning (as reflected in the appellate summary) indicates that the document did not amount to a legally enforceable agreement granting Dr Han a right to hold office in CTP-HZ. The Court therefore rejected the High Court’s conclusion that Dr Han had an enforceable right, or at minimum a legitimate expectation, to remain as chairman and director unless justifiably dismissed. In effect, the Court treated the document as insufficient to constrain the company’s internal governance mechanisms in the way the High Court had assumed.
This reasoning has practical implications for corporate governance disputes. Directors’ appointments and removals are typically governed by the company’s constitution and the Companies Act framework. Parties may attempt to contract for stability of office, but the Court of Appeal’s approach underscores that courts will scrutinise whether the instrument is truly intended and capable of creating enforceable rights against the company and/or other shareholders, rather than merely recording internal understandings or governance arrangements.
Turning to damages, the Court of Appeal held that Dr Han was unable to show that he had suffered any legally recoverable loss. The factual background included a collaboration agreement that guaranteed profit, but the Court noted that the agreement was never registered with Chinese authorities and was therefore unenforceable under Chinese law. That unenforceability undermined the claim that the guaranteed profit could be treated as a loss flowing from the wrongful removal. Even if removal were procedurally or substantively improper, the causal chain and the recoverability of the claimed profits depended on whether the underlying contractual entitlement could be enforced. The Court’s conclusion reflects a strict approach to damages: losses must be legally recoverable and not speculative or dependent on unenforceable arrangements.
In CA 37, the Court of Appeal’s analysis was more deferential. It stated that it was “unable to see any basis whatsoever for overturning the factual findings of the Judge” and therefore dismissed the appeal. This indicates that the counter-claims depended heavily on factual determinations made at trial, including whether the alleged conspiratorial conduct occurred and whether the alleged diversion of opportunities was established. Where the appellate court finds no error in the trial judge’s factual findings, it will not readily interfere, especially in complex commercial disputes where credibility and evidential weight are central.
Although the excerpted judgment text is truncated, the Court’s stated approach is clear: CA 37 failed because the appellants did not demonstrate a basis to disturb the trial court’s factual conclusions. The Court therefore upheld the dismissal of the conspiracy and breach of fiduciary duty claims against Dr Han and the other respondents.
What Was the Outcome?
The Court of Appeal allowed CA 36, overturning the High Court’s decision in Suit 908. The Court held that the 1 March document did not constitute a legally enforceable agreement granting Dr Han enforceable rights to his positions in CTP-HZ. It also found that Dr Han failed to establish legally recoverable loss. As a result, Dr Han’s claim for wrongful removal and damages was not sustained on appeal.
The Court of Appeal dismissed CA 37, thereby upholding the High Court’s dismissal of the counter-claims in Suit 266. The practical effect was that the appellants’ allegations of conspiracy and breach of fiduciary duties against Dr Han and others did not succeed, and the trial court’s factual findings remained undisturbed.
Why Does This Case Matter?
This decision is significant for corporate disputes in Singapore because it clarifies the limits of contractual or quasi-contractual instruments in constraining director removal and office-holding. Parties often document governance arrangements in resolutions, letters, or “side agreements” in joint ventures. The Court of Appeal’s rejection of the High Court’s characterisation of the 1 March document demonstrates that courts will not automatically treat such documents as binding shareholders’ agreements conferring enforceable rights to office. Instead, courts will examine the document’s nature, intended legal effect, and whether it can properly operate to restrict internal corporate decision-making.
For practitioners, the case highlights drafting and litigation strategy points. If parties intend to secure enforceable rights relating to appointments or removals, they must ensure that the instrument is properly structured—potentially as a shareholders’ agreement with clear terms, appropriate parties, and enforceability mechanisms. Merely recording governance intentions in a document labelled as a directors’ resolution may be insufficient.
The damages aspect is equally instructive. The Court of Appeal’s insistence on legally recoverable loss, particularly where the claimed profits depend on an unenforceable underlying contract, reinforces the need for careful assessment of causation and enforceability. In cross-border joint ventures, enforceability under local law can be decisive. Lawyers should therefore evaluate not only whether a wrongful act occurred, but also whether the claimed loss is legally actionable and not contingent on rights that cannot be enforced.
Legislation Referenced
Cases Cited
Source Documents
This article analyses [2014] SGCA 29 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.